New York Times: Battle against biogenerics is on

By Michael Johnsen

NEW YORK — The battle against biogenerics is on, noted a report published in The New York Times Tuesday. As many as eight states have introduced legislation that would restrict generic competition of biological pharamceuticals so far this year and one, the Virginia House of Delegates, already passed such a measure by a 91-to-6 vote.

At the federal level biological manufactures are squaring off against their potential generic competitors on whether or not the generic equivalent can share the same generic name as the brand product, the NYT report noted. If no, then pharmacists will be unable to substitute one for the other even if a state were to allow biogenerics.